Market Analysis

All Reports

Browse our comprehensive collection of market intelligence reports.

Healthcare|March 2020

MRSA Infections Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

MRSA Infections Pipeline Analysis report covers more than 10 drugs currently in different phases of development. MRSA Infections are also known as Methicillin-resistant Staphylococcus Aureus (MRSA) infection caused by a type of Staphylococcus or staph bacteria which is resistant to various antibiotics. These bacteria live naturally in the nose and on the skin and are innocuous till they multiply in an uncontrolled manner causing an MRSA infection. The infections a

Healthcare|March 2020

Synovitis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

Synovitis Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Synovitis is a diseased condition which results due to the inflammation of the tissue lining a joint. It is caused due to the association with specific diseases like arthritis or gout or may be due to the overuse or trauma as well. Symptoms include redness, swelling, pain of the joints with motion and the treatment includes rest, ice, immobilization and anti-inflammatory drugs. Surg

Healthcare|March 2020

Atypical Hemolytic Uremic Syndrome (aHUS) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Atypical hemolytic uremic syndrome (aHUS) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Atypical hemolytic uremic syndrome (aHUS) Pipeline Analysis report covers 10 drugs currently in different phases of development. Atypical hemolytic-uremic syndrome is a rare renal disease characterised by abnormal clotting: ha

Healthcare|March 2020

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis report covers 12 drugs currently in different phases of development. Mucopolysaccharidosis III is a rare inherited autosomal recessive disorder characterised by progressive dementia, aggressive behavior, hyperactivity, seizure

Healthcare|March 2020

Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis 2018 (H1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis report covers 11 drugs currently in different phases of development. Hurler Syndrome is an inherited lysosomal storage disease caused by defect in IDUA gene. The defect in the gene results in deficiency of al

Healthcare|March 2020

Becker Muscular Dystrophy Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

Becker Muscular Dystrophy Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Becker Muscular Dystrophy (BMD) Pipeline Analysis report covers 6 drugs currently in different phases of development. Becker muscular dystrophy is an X-linked recessive genetic disorder characterized by progressive weakness and wasting of the skeletal and cardiac muscles and is caused by is caused by a mutation i

Healthcare|March 2020

Duchenne Muscular Dystrophy (DMD) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

Duchenne Muscular Dystrophy (DMD) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Duchenne Muscular Dystrophy (DMD) Pipeline Analysis report covers 40 drugs currently in different phases of development. Duchenne Muscular Dystrophy (DMD) is a genetic disorder caused by the absence of a protein known as dystrophin. T

Healthcare|March 2020

IgA Nephropathy Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

IgA Nephropathy Pipeline Analysis report covers 17 drugs currently in different phases of development. IgA Nephropathy is also known as Berger’s disease occurs when there is an accumulation of immunoglobulin A (IgA) in the kidneys. This gives rise to kidney inflammation and may damage the kidney’s ability to filter waste, slowly with time. The disease is asymptomatic in the beginning and can be detected only by routine tests. Presence of protein and red blood cells in the uri

Healthcare|March 2020

Fabry’s Disease Pipeline Analysis 2019 (H1)

Fabry’s Disease Pipeline Analysis report covers more than 15S drugs currently in different phases of development. Fabry’s disease is a rare genetic disorder caused mostly in males than females due to the deficiency of the alpha-galactosidase A (a-Gal A) enzyme which causes a build-up of a type of fat, globotriaosylceramide (Gb3, or GL-3) in the bod

Healthcare|March 2020

Progressive Supranuclear Palsy (PSP) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.

Progressive Supranuclear Palsy Pipeline Analysis report covers 8 drugs currently in different phases of development. Progressive Supranuclear Palsy or Steele-Richardson-Olszewski syndrome is a rare brain related disorder which affects body movement, eye movement, balance of the body. It is a FTD disorder associated with a decline in motor function and is similar to Parkinson’s disease. Symptoms include loss of balance, slurring of speech, abnormal eye movements and urinary in

Healthcare|March 2020

Plaque Psoriasis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

Plaque Psoriasis Pipeline Analysis report covers 41 drugs currently in different phases of development. Plaque Psoriasis is the most type of Psoriasis and is a chronic, relapsing, inflammatory and inherited skin disorder. The disease is not life threatening but often intractable to treatment. Symptoms of the disease include appearance ofthe Plaques of red skin mostly covered with lose silver coloured scales, discoloration or pitting of nails and plaques of scales

Healthcare|March 2020

Neutropenia Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Neutropenia Pipeline Analysis report covers 23 drugs currently in different phases of development. Neutropenia means extremely low count of neutrophils in body. Neutrophils are the type of white blood cells and destroy bacteria and other organisms that cause infection. With the lack of neutrophils in the body people with neutropenia are more likely to develop infections. Neutropenia may be congenital or may be acquired as a result of cancer and cancer treatm